Giacomo Nuvola

4PUBLICATIONS
12CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 18, 2023
The future of immunotherapy in advanced renal cell carcinoma: beyond PD-1/PD-L1 inhibitors.

Giacomo Nuvola, Veronica Mollica, Francesco Massari

|Sep 09, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.

Alessandro Rizzo, Veronica Mollica, Andrea Marchetti

|Jan 10, 2022
The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: will immunotherapy solve the problem?

Giacomo Nuvola, Alessandro Rizzo, Veronica Mollica

|Jul 02, 2021
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?

Andrea Marchetti, Matteo Rosellini, Veronica Mollica

Pageof 1